Figure 5From: Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study ROC curve for validity of pretreatment ALT for moderate vs. minimal inflammation. Part ‘a’ shows AUROC of pre-treatment ALT for moderate compared to minimal liver inflammation in males, having a value of 0.696. Part ‘b’ shows AUROC of pre-treatment ALT for moderate compared to minimal liver inflammation in females, a value of 0.688. Pre-treatment ALT is less accurate in measuring moderate as compared to minimal inflammation in both genders.Back to article page